Changying Liu

Title: Changying Liu: Innovator in Pharmaceutical Research

Introduction

Changying Liu is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of urate transporter inhibitors. With a total of three patents to his name, Liu's work is characterized by innovation and practical applications in medicine.

Latest Patents

Liu's latest patents include a crystal form of urate transporter 1 inhibitor and a preparation method and use thereof. This invention provides a crystal form that is stable in appearance and enhances the purity and storage stability of the compound, making it suitable as a pharmaceutical raw material. Another notable patent is a method for preparing a URAT1 inhibitor, specifically 2-((5-bromo-4-((4-bromonaphthalen-1-yl)methyl)-4H-1,2,4-triazol-3-yl)thio) acetic acid. This method is distinguished by its low cost, ease of handling, and applicability to industrialization, representing a significant advancement over prior art.

Career Highlights

Changying Liu is affiliated with the Tianjin Institute of Pharmaceutical Research Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work has not only contributed to the scientific community but has also paved the way for new therapeutic options in medicine.

Collaborations

Liu collaborates with esteemed colleagues such as Guilong Zhao and Huihui Chen, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Changying Liu stands out as a key figure in pharmaceutical research, with his innovative patents and collaborative efforts driving advancements in the field. His contributions are vital for the development of effective medical treatments.